American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
Harvard Apparatus Regenerative Technology, Inc.
$1.08
-3.57%
OTC: HRGN · 15-min delayed
$704.0KRevenue · FY2025
-$6.9MNet income
HRGNOTC
About Harvard Apparatus Regenerative Technology, Inc.
HARVARD APPRATS REG TCH
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $704.0K
- Net income
- -$6.9M
- Total assets
- $2.7M
Source: SEC EDGAR · updated Jun 7, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $6.9M in FY2025.
- Trading 51% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Harvard Apparatus Regenerative Technology, Inc..
Write a review
Newsroom
News about Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
News & sentiment via Polygon.io
Explore
Browse all →
